Type 2 & other diabetes

Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI

Cardiovasc DiabetolPublished Cohort study

Authors' conclusion

We showed a U-shaped association of glycemic control with clinical outcomes in patients with T2DM and HFrEF, with the lowest risk of adverse outcomes among patients with modest glycemic control. HbA1c between 6.5% and 7.5% may be served as the optimal hypoglycemic target in this specific population.

Study context

Population
Patients with T2D and heart failure with reduced ejection fraction (HFrEF) who underwent cardiac MRI
Participants
262 patients
Exposure
HbA1c <6.5% and HbA1c >7.5% vs HbA1c 6.5-7.5%
Outcome
Primary outcomes
Follow-up
Median 35.0 months
Methodological detailscardiac MRI
  • Cardiac MRI

Main finding

As reported in the abstract

Each group vs modest controlHazard ratio (95% CI)P value
Intensive control
2.42(1.07–5.45)
P = 0.033
Poor control
2.24(1.01–4.99)
P = 0.038
Patients with at least one confirmed endpoint event
55 patients (21.0%)

Observational data: associations, not effects.

Secondary outcomes

OutcomeHR (95% CI)P value
Secondary outcomes · median follow-up 35.0 monthsIntensive controlvs Modest controlCox multivariable analysis2.84 (1.16–6.96)P = 0.022
Secondary outcomes · median follow-up 35.0 monthsPoor controlvs Modest controlCox multivariable analysis2.65 (1.08–6.50)P = 0.038

Left ventricular (LV) longitudinal systolic strain

Despite similar biventricular ejection fractions, intensive and poor glycemic control showed prominent deterioration of LV longitudinal systolic strain
P = 0.004

Original publication

Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI. Cardiovasc Diabetol. Published 29 April 2024. doi:10.1186/s12933-024-02243-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.